The Protein Therapeutics Market is projected to reach USD 645.61 billion by 2032, growing at a CAGR of 7.03% driven by increasing prevalence of diseases and biotechnology advancements. The US market is expected to rise to USD 206.89 billion by 2032 with strong clinical pipelines and FDA approvals. Monoclonal antibodies hold 43% market share, while metabolic disorders dominate applications.
North America leads the global protein therapeutics market with 46% revenue share in 2024. Asia Pacific is projected to grow at the highest CAGR due to expanding patient population and healthcare spending. Major players in the market include Bayer AG, Bristol-Myers Squibb, Abbott, Sanofi, and more. Recent developments include AbbVie’s acquisition of Capstan Therapeutics and FDA approval of telisotuzumab vedotin.
Exclusive sections of the report cover disease incidence, prescription trends, bioimmunologic disorders spending, manufacturing statistics, technological advancements, and competitive benchmarking insights. The report provides a comprehensive scope including market size in 2024, forecast for 2032, key segments by product and applications, regional analysis, and complete report details.
SNS Insider is a leading market research and consulting agency providing clients with knowledge to navigate changing circumstances. For more information or customized research on the Protein Therapeutics Market, visit their website or contact them via email. 1. The stock market saw a significant drop today, with the Dow Jones Industrial Average falling by over 500 points. This was due to concerns about rising inflation and interest rates, leading to a sell-off in tech and growth stocks.
2. In other news, the CDC reported a spike in COVID-19 cases in several states, attributing the increase to the highly contagious Delta variant. Hospitalizations have also risen, prompting renewed calls for vaccination and mask-wearing.
3. On a more positive note, the latest jobs report showed a decrease in unemployment rates, with 600,000 new jobs added in the past month. This marks a step towards economic recovery following the pandemic-induced downturn.
4. In international news, tensions have escalated between Russia and Ukraine, with reports of increased military activity along the border. The US and NATO have expressed concern over the situation, calling for a peaceful resolution to the conflict.
Read more at GlobeNewswire: Protein Therapeutics Market Set to Hit USD 645.61 Billion